solcitinib   Click here for help

GtoPdb Ligand ID: 9697

Synonyms: compound 1 [WO2010149771] | GLPG-0778 | GLPG0778 | GSK2586184
Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: Solcitinib is a Janus kinase 1 (JAK1)-selective inhibitor, with anti-inflammatory activity [1].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 1
Rotatable bonds 6
Topological polar surface area 79.6
Molecular weight 389.19
XLogP 3.08
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES O=C(C1CC1)Nc1nn2c(n1)cccc2c1ccc(cc1)C(=O)N1CC(C1)(C)C
Isomeric SMILES O=C(C1CC1)Nc1nn2c(n1)cccc2c1ccc(cc1)C(=O)N1CC(C1)(C)C
InChI InChI=1S/C22H23N5O2/c1-22(2)12-26(13-22)20(29)16-10-6-14(7-11-16)17-4-3-5-18-23-21(25-27(17)18)24-19(28)15-8-9-15/h3-7,10-11,15H,8-9,12-13H2,1-2H3,(H,24,25,28)
InChI Key MPYACSQFXVMWNO-UHFFFAOYSA-N
No information available.
Summary of Clinical Use Click here for help
Clinical development progressed to Phase 2 in patients with systemic lupus erythematosus (SLE) [2] and patients with psoriasis [3]. Study results showed clinical efficacy in moderate-to-severe psoriasis but not in SLE. The development programme has since been terminated.